UH-232

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

UH-232 topic overview

The analysis highlights History, Applications and Research as prominent areas in the source structure around UH-232.

Related topics: 83
Source areas: 6
Connected nodes: 89
Extracted relationships: 64
Concept neighborhoods: 27
Bridge connections: 89

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Pharmacology · 35 topics

Chemistry · 20 topics

Overview · 10 topics

Use and effects · 8 topics

Research · 6 topics

History · 4 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol): Interactive image
ATC code: None
Bioavailability: 3.7% (rats)
CAS Number: 95999-12-5 Y
ChEBI: CHEBI:114198
ChEMBL: ChEMBL278751

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

History

Research

Phase 1 Phases of clinical research
Anxiety
Activation Stimulation
Hostility
Diagnosis
Parkinson's disease

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How UH-232 connects Entity context

The extracted context around UH-232 shows recurring relationship patterns in the source. For example, UH-232 → AJ-76, Another, DOM-AT, DPT, HMDPT, In, OH-DPAT, OH-MDAT, Other, PNU-99, RDS-127, RU-28251, The N-monopropyl, UH-232RU-28251NDTDILSD, UH-242, UH-301 Another extracted example is UH-232 → Accordingly, D1, D2, D2Sh, D3, D4, However, HT1A, HT2, HT2A, In, It, Its, Ki, The. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to Analogues · 16

UH-232 → AJ-76, Another, DOM-AT, DPT, HMDPT, In, OH-DPAT, OH-MDAT, Other, PNU-99, RDS-127, RU-28251, The N-monopropyl, UH-232RU-28251NDTDILSD, UH-242, UH-301

related to Pharmacodynamics · 15

UH-232 → Accordingly, D1, D2, D2Sh, D3, D4, However, HT1A, HT2, HT2A, In, It, Its, Ki, The

related to Research · 5

UH-232 → Besides, Instead, It, Parkinson's, The

has effect · 3

UH-232 → Based, HT2A, The

related to history · 3

UH-232 → Arvid Carlsson, AstraZeneca, It

is a · 2

UH-232 → functional antagonist or partial agonist of the dopamine receptors in humans.In addition to the dopamine D2 and D3 receptors, substituted 2-aminotetralin

3D model (JSmol) · 1

UH-232 → Interactive image

ATC code · 1

UH-232 → None

Bioavailability · 1

UH-232 → 3.7% (rats)

CAS Number · 1

UH-232 → 95999-12-5 Y

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

dopamine effects receptor serotonin d2 hallucinogenic also d3 drug schizophrenia antagonist partial 5-ht2a treatment reported agonist 2-aminotetralin receptors 5-ht2 stimulant-like

UH-232 relationships Subject–Predicate–Object triples

TTTA extracted 64 structured relationships around UH-232. Examples in this analysis include UH-232 → 3D model (JSmol) → Interactive image and UH-232 → ATC code → None. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
UH-232	3D model (JSmol)	Interactive image	1.00	infobox
UH-232	ATC code	None	1.00	infobox
UH-232	Bioavailability	3.7% (rats)	1.00	infobox
UH-232	CAS Number	95999-12-5 Y	1.00	infobox
UH-232	ChEBI	CHEBI:114198	1.00	infobox
UH-232	ChEMBL	ChEMBL278751	1.00	infobox
UH-232	ChemSpider	5037017	1.00	infobox
UH-232	CompTox Dashboard (EPA)	DTXSID70875101	1.00	infobox
UH-232	Drug class	Dopamine D2 receptor antagonist; Dopamine D3 receptor weak partial agonist; Serotonin 5-HT2A receptor agonist; Hallucinogen; Serotonergic psychedelic	1.00	infobox
UH-232	Elimination half-life	2.5 hours (rats)	1.00	infobox
UH-232	Formula	C18H29NO	1.00	infobox
UH-232	Metabolites	AJ-76	1.00	infobox
UH-232	Molar mass	275.436 g·mol−1	1.00	infobox
UH-232	Other names	UH232; (+)-UH-232; (+)-UH232; (+)-cis-5-Methoxy-1-methyl-2-(dipropylamino)tetralin; 5-HMDPTME; 5-Hydroxy-1-methyl-2-(dipropylamino)tetralin methyl ether	1.00	infobox
UH-232	PubChem CID	6604756	1.00	infobox
UH-232	Routes of administration	Oral	1.00	infobox
UH-232	UNII	QQYOR9S587	1.00	infobox
UH-232	is a	functional antagonist or partial agonist of the dopamine receptors in humans.In addition to the dopamine D2 and D3 receptors	0.90	text
UH-232	is a	substituted 2-aminotetralin	0.90	text

Related concept clusters Concept neighborhoods

The concept neighborhoods around UH-232 bring nearby vocabulary together. In this analysis, examples include Partial, Humans and Hyperlocomotion. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

dopamine
- D2
- Receptor
- D3
- Antagonist
- Serotonin
- Receptors
- Uh-232
- Affinity
- Ki
- 5-ht2
- Agonist
- Partial
serotonin receptor modulator
- D2
- D3
- Receptor
- Serotonin
- 5-ht2
- 5-ht2a
- May
- Tetralin
- Affinity
- Agonist
- Ki
- Receptors
serotonin
- Receptor
- 5-ht2
- 5-ht2a
- May
- D2
- Tetralin
- D3
- Affinity
- Agonist
- Receptors
- Reported
- Uh-232
5-ht2a receptor
- May
- D2
- D3
- Serotonin
- 5-ht2a
- Receptor
- Agonist
- Reported
- 5-ht2
- Hallucinogenic
- Partial
- Affinity
d2
- D3
- Dopamine
- Receptor
- Affinity
- 5-ht2
- Receptors
- Serotonin
- Antagonist
- Ki
- Weak
- Agonist
- Partial
d3 receptor
- D2
- D3
- Receptor
- Serotonin
- Dopamine
- Affinity
- 5-ht2a
- Receptors
- 5-ht2
- Ki
- Weak
- Agonist
antagonist
- Agonist
- Dopamine
- Partial
- Humans
- Weak
- D2
- Drug
- D3
- Serotonin
- Receptor
- Dipropylamino
- Ether
partial agonist
- Antagonist
- Partial
- Humans
- Weak
- Reported
- 5-ht2a
- Drug
- Dopamine
- Uh-232
- D2
- D3
- Dipropylamino

Connections between topic areas Semantic bridges

For UH-232, one of the stronger structural bridges in this analysis connects UH-232 with Pharmacology. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

UH-232 — Pharmacology · splits 54 ⟂ 36

UH-232 — Chemistry · splits 69 ⟂ 21

UH-232 — Overview · splits 79 ⟂ 11

UH-232 — Use and effects · splits 81 ⟂ 9

UH-232 — Research · splits 83 ⟂ 7

UH-232 — History · splits 85 ⟂ 5

Map overview Semantic statistics

UH-232

Nodes90

Edges89

Triples64

Avg. degree1.98

Density0.022222

Components1

Source & methodology

TTTA analyzes the structure around UH-232 to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications & Research, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — UH-232 · EN edition · Analysis: TopicsToTalkAbout